| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000027541 |
| Receipt No. | R000031573 |
| Scientific Title | Clinical trial of boron neutron capture therapy utilizing research reactor for skin malignant tumors |
| Date of disclosure of the study information | 2017/08/01 |
| Last modified on | 2020/03/03 (Ver. 4) |
| Basic information | ||
| Public title | Clinical trial of boron neutron capture therapy utilizing research reactor for skin malignant tumors | |
| Acronym | Clinical trial of skin malignancy BNCT | |
| Scientific Title | Clinical trial of boron neutron capture therapy utilizing research reactor for skin malignant tumors | |
| Scientific Title:Acronym | Clinical trial of skin malignancy BNCT | |
| Region |
|
|
| Condition | ||
| Condition | skin malignant tumors | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | effectiveness |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | tumor response rate and adverse events 6 months after BNCT |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | BPA is administrated as boron carrier and reactor is utilized as neutron source. | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.skin tumors that have relapsed after conventional therapies
2.inoperable skin malignant tumors 3.Without distant metastases 4.PS: less than 2 5.Consent to perform BNCT 6.With the approval of the Medical Ethics Committee 7.Japanese at the age of 16 to 89 |
|||
| Key exclusion criteria | 1.with severe complications or double cancers
2.first therapy induced more than Grade 3 side effect 3.medically or socially unacceptable patients |
|||
| Target sample size | 10 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kawasaki Medical School | ||||||
| Division name | Radiation Oncology | ||||||
| Zip code | |||||||
| Address | 577 Matsushima, Kurashiki city | ||||||
| TEL | 086-462-1111 | ||||||
| hiratuka@med.kawasaki-m.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kawasaki Medical School | ||||||
| Division name | Division of Reseach Support | ||||||
| Zip code | |||||||
| Address | 577 Matsushima, Kurashiki city | ||||||
| TEL | 086-462-1111 | ||||||
| Homepage URL | |||||||
| kenkyu-idai@med.kawasaki-m.ac.jp | |||||||
| Sponsor | |
| Institute | kawasaki Medical School |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japanese Government |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031573 |